ARVC Screening Probability in Athletes (Family History + ECG) Calculator

Clinical calculation support · Verify results before clinical use

Screening findings

Record relevant family-history and ECG features. This checklist does not calculate a validated disease probability.

0Red flags
1

Used to contextualize ECG findings; age alone is not assigned a risk point.

2
Sex

For clinical context only; no score weighting is applied.

!
First-degree relative with definite ARVC/ACM or a known familial pathogenic variant

A known familial pathogenic/likely pathogenic variant should be interpreted with genetic counselling and the family-specific report.

!
Family history of sudden cardiac death before age 40

Clarify relationship, age, circumstances, and whether the death was unexplained or suspected to be cardiac.

!
Anterior T-wave inversion beyond V2 in an athlete aged 16 years or older

Context matters: ethnicity, J-point/ST-segment pattern, complete RBBB, symptoms, and other findings affect interpretation.

!
Inferolateral T-wave inversion in at least 2 contiguous leads

Abnormal athlete ECG pattern requiring evaluation for structural or electrical heart disease; not specific for ARVC.

!
Terminal activation duration ≥55 ms in V1–V3 without complete RBBB

Measure according to standard ECG criteria; this finding alone is not diagnostic.

!
Epsilon wave reported on ECG

Requires expert ECG review because reproducibility and specificity can be limited.

HR

Recorded for context only; heart rate is not part of a validated ARVC screening probability model in this tool.

—
Screening summary
Complete the patient details
Select the applicable findings to generate a structured summary. No percentage probability will be inferred.
Suggested clinical action

Interpret the findings alongside symptoms, examination, full 12-lead ECG, and the athlete's personal and family history.

This is a non-validated checklist, not a diagnostic score, risk calculator, or sports-clearance decision rule. A zero count does not exclude disease.

Clinical context

Arrhythmogenic cardiomyopathy (ACM), including the classic right-ventricular phenotype historically termed ARVC, is diagnosed using a multiparametric assessment. Family history and ECG findings can raise suspicion, but no single item in this checklist establishes or excludes the diagnosis.

Findings that warrant further evaluation

  • A first-degree relative with confirmed disease or a known familial disease-causing variant.
  • Unexplained premature sudden death in the family, particularly where a cardiac cause is suspected.
  • Pathological T-wave inversion, epsilon waves, or prolonged terminal activation in an appropriate clinical context.
  • Syncope during exercise, sustained palpitations, ventricular ectopy/ventricular tachycardia, or abnormal cardiac imaging.

Potential evaluation

Depending on the presentation, specialist assessment may include expert ECG review, echocardiography, cardiac magnetic resonance, ambulatory ECG monitoring, exercise testing, and genetic counselling/testing when indicated. Exercise advice and temporary restriction should be individualized by the treating team; do not use this checklist alone to clear an athlete.

Important ECG qualifications

Anterior T-wave inversion can be a normal variant in some athletes, including certain patterns in Black athletes and athletes younger than 16 years. Complete right bundle branch block and J-point/ST-segment morphology also influence interpretation. Inferolateral T-wave inversion is not specific to ARVC and has a broader differential diagnosis.

Evidence and references

Marcus FI, McKenna WJ, Sherrill D, et al.Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation. 2010;121:1533–1541. doi:10.1161/CIRCULATIONAHA.108.840827
Drezner JA, Sharma S, Baggish A, et al.International criteria for electrocardiographic interpretation in athletes: Consensus statement. Br J Sports Med. 2017;51:704–731. doi:10.1136/bjsports-2016-097331
Arbelo E, Protonotarios A, Gimeno JR, et al.2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44:3503–3626. doi:10.1093/eurheartj/ehad194
Sharma S, Drezner JA, Baggish A, et al.International recommendations for electrocardiographic interpretation in athletes. J Am Coll Cardiol. 2017;69:1057–1075. doi:10.1016/j.jacc.2017.01.015
Clinical disclaimer: This educational screening checklist is not a validated probability model and does not provide an individual percentage risk. It cannot diagnose or rule out ARVC/ACM and must not be used as the sole basis for treatment, genetic testing, or sports participation decisions. Concerning symptoms such as exertional syncope or sustained palpitations require prompt clinical assessment.